Algorae Pharmaceuticals Ltd (1AI) — Cash Flow Reinvestment Rate

Latest as of September 2013: 0.01x

Algorae Pharmaceuticals Ltd (1AI) has a Cash Flow Reinvestment Rate of 0.01x as of September 2013, reinvesting AU$5.00K (capex AU$5.00K ) from operating cash flow of AU$334.25K. Check 1AI cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.01x

(Capex + Investments) / Operating CF

Total Reinvested

AU$5.00K

Capex + Investments

Operating Cash Flow

AU$334.25K

AUD

Capital Expenditures

AU$5.00K

AUD

Algorae Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2013–2013)

Historical reinvestment intensity for Algorae Pharmaceuticals Ltd across 1 annual periods. Explore 1AI long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Algorae Pharmaceuticals Ltd (2013–2013)

Year-by-year capital reinvestment analysis for Algorae Pharmaceuticals Ltd. For live market cap and broader valuation context, see 1AI company net worth.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2013	0.01x	AU$20.00K	AU$1.34 Million	AU$20.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow